Characterisation of the cutaneous pathology in non-small cell lung cancer (NSCLC) patients treated with the EGFR tyrosine kinase inhibitor erlotinib

Autor:	Guttman-Yassky, Emma, Mita, Alain, De Jonge, Maja, Matthews, Lesley, McCarthy, Sean, Iwata, Kenneth K., Verweij, Jaap, Rowinsky, Eric K., Krueger, James G.
Zdroj:	In European Journal of Cancer 2010 46(11):2010-2019
Databáze:	ScienceDirect
Externí odkaz:	Zobrazit plný text záznamu Full Text from ScienceDirect